| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |